drugset / Trial / NCT00674141
Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study aims to assess the safety and efficacy of nasale administration of Dexamethasone in relapsing MS patients
Timeline
- Start
- 2008-07
- Primary completion
- 2008-12
- Completion
- 2009-01
Outcome
Outcome not reported
Stopped: “was not approved by the ministry of health”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 20 mg | Intranasal |